Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Diplomat Pharmacy, Inc.
Traded as NYSE: DPLO
S&P 600 Component

Diplomat Pharmacy, Inc., is the largest independent specialty pharmacy in the United States. Headquartered in Flint, Michigan, Diplomat has facilities across the United States and dispenses drugs in all 50 states. Diplomat offers specialized medication and medication management programs for patients with complex and chronic conditions such as cancer, hepatitis, multiple sclerosis, HIV and others.

In October 2014, Diplomat Pharmacy launched an initial public offering (IPO) on the New York Stock Exchange after raising $173 million. Diplomat is the only publicly traded independent specialty pharmacy in the United States. Diplomat currently ranks 29th in the state of Michigan on the list of the top publicly traded companies based on revenues.

Diplomat distributes oncology medications in a CarePak™, specially designed to improve patient adherence. Diplomat also serves as the specialty pharmacy for many retail pharmacies, hospitals and health systems throughout the United States.

Diplomat is accredited by several third-party agencies, including URAC, the American Society of Health-System Pharmacists, and the Accreditation Commission for Health Care.

For hemophilia and other blood disorder patients, they offer in-home and outpatient specialty infusion services.

Dale Hagerman founded Diplomat Pharmacy in 1975 in Flint, Michigan. For over 40 years, Diplomat has been working with patients living with chronic diseases. In 2009, Diplomat moved its headquarters back to Flint from Swartz Creek, Michigan. In 2014, Diplomat ranked 69th on the Inner City 100 list of fastest growing companies based in inner cities.

In July 2014, Diplomat acquired MedPro Rx, a specialty pharmacy based in North Carolina.

In February 2015, Diplomat acquired BioRx, a specialty pharmacy in Cincinnati, Ohio for $315 million. According to documents filed with the Securities and Exchange Commission, the purchase "added significant scale to [Diplomat's] specialty infusion services.

In June 2015, Diplomat acquired Philadelphia-based Burman’s Specialty Pharmacy for $73 million, growing their geographic presence.

On October 9, 2017, co-founder Dale Hagerman died at the age of 90.

Investment goal date:
Dividends reinvested
Diplomat Pharmacy, Inc. DPLO report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BALYASNY ASSET MANAGEMENT LLC
1947393
BlackRock Fund Advisors
3778238
BlackRock Inc.
5548617
Cambridge Investment Research Advisors, Inc.
1337070
CITADEL ADVISORS LLC
1742829
Clearbridge Investments, LLC
1232835
DAVIS SELECTED ADVISERS
1632146
FRONTIER CAPITAL MANAGEMENT CO LLC
5455461
HERMES INVESTMENT MANAGEMENT LTD
1772777
JANUS CAPITAL MANAGEMENT LLC
5361171
PRICE T ROWE ASSOCIATES INC /MD/
1409960
Redmile Group, LLC
1254342
RIVERBRIDGE PARTNERS LLC
1464286
STATE STREET CORP
1244255
Vanguard Group, Inc
3866811
Major Shareholders
Name Relationship
Total Shares
Holding stocks